Hugen Pharmaceuticals Inc San Diego, CA - 92122

Hugen Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in San Diego, CA and active since 2012.

Hugen Pharmaceuticals Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Chun Shen at the company’s single location by writing to 8895 Twne Cntre Drive 105, San Diego, California CA 92122 or by phoning (858) 531-8888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hugen Pharmaceuticals Inc
Contact Person: Chun Shen
Address: 8895 Twne Cntre Drive 105, San Diego, California 92122
Phone Number: (858) 531-8888
Annual Revenue (USD): $100.000 to $499.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Wholesale Pharmaceutical Products
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Hugen Pharmaceuticals Inc was started in 2012 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Chun Shen for inquiries that concern Hugen Pharmaceuticals Inc by calling the company number (858) 531-8888, as your correspondence is most welcome. Additionally, the physical location of the single location of Hugen Pharmaceuticals Inc can be found at the coordinates 32.867673,-117.207042 as well as the street address 8895 Twne Cntre Drive 105 in San Diego, California 92122.

For its online presence, you may visit Hugen Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.